Recruiting Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas NCT03258567 Conditions DNA Virus Infections, Disorders, Lymphoproliferative, Epstein-Barr Virus Infections, +13 more Locations National Institutes of Health Clinical Center — Bethesda, Maryland, United States View Trial Details